DexCom Aktie
58,39
EUR
-2,19
EUR
-3,62
%
69,22
USD
-0,04
USD
-0,05
%
Werbung
DexCom Aktie Analyse
| 02.08.18 | DexCom Buy | Canaccord Adams | |
| 03.05.18 | DexCom Buy | Canaccord Adams | |
| 23.03.18 | DexCom Outperform | Robert W. Baird & Co. Incorporated | |
| 28.09.17 | DexCom Outperform | Wedbush Morgan Securities Inc. | |
| 15.09.17 | DexCom Equal weight | Barclays Capital | |
| 03.05.17 | DexCom Buy | Canaccord Adams | |
| 02.11.16 | DexCom Buy | Canaccord Adams | |
| 24.02.16 | DexCom Buy | The Benchmark Company | |
|
Werbung
|
|||
| 06.08.15 | DexCom Buy | Canaccord Adams | |
| 08.07.15 | DexCom Outperform | Robert W. Baird & Co. Incorporated | |
| 30.04.15 | DexCom Perform | Oppenheimer & Co. Inc. | |
| 27.01.15 | DexCom Perform | Oppenheimer & Co. Inc. | |
| 24.10.06 | DexCom Outperform | Piper Jaffray | |
Werbung
Werbung